Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta

Songyi Xu1, Amber C Liu, Avrum I Gotlieb

  • 1Toronto General Research Institute and Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.

Insights

Calcific aortic stenosis and atherosclerosis share similar pathways. Transforming growth factor-beta may be a key therapeutic target for both cardiovascular diseases.

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Biochemistry

Background:

  • Calcific aortic stenosis and atherosclerosis are distinct cardiovascular conditions.
  • Similarities in pathogenesis suggest shared underlying mechanisms.
  • Current therapies, like statins, show effects potentially independent of lipid lowering.

Purpose of the Study:

  • To discuss the pathogenic features of calcific aortic stenosis and atherosclerosis.
  • To highlight the similarities between these two cardiovascular diseases.
  • To review evidence for transforming growth factor-beta as a shared therapeutic target.

Main Methods:

  • Review of experimental in vitro and in vivo studies.
  • Analysis of clinical studies on both conditions.
  • Literature synthesis on molecular regulatory roles.

Main Results:

  • Identified significant similarities in pathogenic pathways between the two diseases.
  • Highlighted the role of various molecules in valve calcification and atherosclerotic plaque progression.
  • Presented evidence suggesting transforming growth factor-beta's regulatory role in both conditions.

Conclusions:

  • Transforming growth factor-beta is a potential key therapeutic target for both calcific aortic stenosis and atherosclerosis.
  • Further study of transforming growth factor-beta is warranted for developing novel treatments.
  • Understanding shared pathways may lead to more effective cardiovascular disease management.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...